`To:
`
`Cc:
`Subject:
`Date:
`
`Malik, Jitty
`Mahaffy, Shaun; Pacchioli, Alissa M.; West, Christopher W.; Radeke, Heike Simone; Pacchioli, Alissa M.; Van
`Buskirk, Tedd W.; Teschner, Michael H.; Faegenburg, Russell W.; Wong, Jovial; Fundakowski, Claire
`(CFundakowski@winston.com); Fischer, Sarah; Zullow, Keith A
`Merck-Sitagliptin
`RE: IPR2020-00040, IPR2020-01045, IPR2020-01060, IPR2020-01072
`Monday, June 29, 2020 1:35:17 PM
`
`Counsel,
`
`Mylan is in receipt of your letter. To that end, and speaking only on behalf of Mylan, Mylan remains
`opposed to any change in the current schedule. See IPR2020-00040 (Paper 32). To that end, Dr.
`Chorghade will be made available for his deposition on July 22nd. Due to the current COVID
`pandemic, and for the health and safety off all concerned, Dr. Chorghade will be made available only
`for a remote deposition. Please let Mylan know if Merck has any objection to proceeding on this
`date.
`
`Thanks,
`
`Jitty
`
`Jitendra (“Jitty”) Malik Ph.D.
`Partner
`Katten
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite 2900 | Charlotte, NC 28202-4213
`direct +1.704.344.3185
`jitty.malik@katten.com | katten.com
`
`From: Mahaffy, Shaun <SMahaffy@wc.com>
`Sent: Friday, June 26, 2020 5:22 PM
`To: Malik, Jitty <jitty.malik@katten.com>; Pacchioli, Alissa M. <alissa.pacchioli@katten.com>; West,
`Christopher W. <christopher.west@katten.com>; Radeke, Heike Simone
`<heike.radeke@katten.com>; Malik, Jitty <jitty.malik@katten.com>; Pacchioli, Alissa M.
`<alissa.pacchioli@katten.com>; Van Buskirk, Tedd W. <tvanbuskirk@lernerdavid.com>; Teschner,
`Michael H. <mteschner@lernerdavid.com>; Faegenburg, Russell W.
`<rfaegenburg@lernerdavid.com>; Wong, Jovial <JWong@winston.com>; Fundakowski, Claire
`(CFundakowski@winston.com) <CFundakowski@winston.com>; Fischer, Sarah
`<SFischer@goodwinlaw.com>; Zullow, Keith A <KZullow@goodwinlaw.com>
`Cc: Merck-Sitagliptin <MerckSitagliptin@wc.com>
`Subject: IPR2020-00040, IPR2020-01045, IPR2020-01060, IPR2020-01072
`
`EXTERNAL EMAIL – EXERCISE CAUTION
`Counsel,
`
`Please see the attached correspondence.
`
`
`Merck Sharp & Dohme Corp. Exhibit 2027
`Teva Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-01045
`Page 1
`
`
`
`Regards,
`Shaun
`
`Shaun P. Mahaffy
`Associate | Williams & Connolly LLP
`725 Twelfth Street, N.W., Washington, DC 20005
`(P) 202-434-5554 | (F) 202-434-5029
`smahaffy@wc.com | www.wc.com
`
`
`
`This message and any attachments are intended only for the addressee and may contain information that is
`privileged and confidential. If you have received this message in error, please do not read, use, copy, distribute, or
`disclose the contents of the message and any attachments. Instead, please delete the message and any attachments
`and notify the sender immediately. Thank you.
`===========================================================
`CONFIDENTIALITY NOTICE:
`This electronic mail message and any attached files contain information
`intended for the exclusive
`use of the individual or entity to whom it is addressed and may contain
`information that is
`proprietary, privileged, confidential and/or exempt from disclosure under
`applicable law. If you
`are not the intended recipient, you are hereby notified that any viewing,
`copying, disclosure or
`distribution of this information may be subject to legal restriction or
`sanction. Please notify
`the sender, by electronic mail or telephone, of any unintended recipients and
`delete the original
`message without making any copies.
`===========================================================
`NOTIFICATION: Katten Muchin Rosenman LLP is an Illinois limited liability
`partnership that has
`elected to be governed by the Illinois Uniform Partnership Act (1997).
`===========================================================
`
`Merck Sharp & Dohme Corp. Exhibit 2027
`Teva Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-01045
`Page 2
`
`